- Home
- DNTH vs TECX Comparison
DNTH vs TECX Comparison
Compare DNTH & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- TECX
- Stock Information
- Founded
- DNTH 2015
- TECX 2019
- Country
- DNTH United States
- TECX United States
- Employees
- DNTH N/A
- TECX N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- TECX
- Sector
- DNTH Health Care
- TECX
- Exchange
- DNTH Nasdaq
- TECX Nasdaq
- Market Cap
- DNTH 711.2M
- TECX 647.7M
- IPO Year
- DNTH N/A
- TECX 2018
- Fundamental
- Price
- DNTH $21.66
- TECX $41.38
- Analyst Decision
- DNTH Strong Buy
- TECX Strong Buy
- Analyst Count
- DNTH 9
- TECX 5
- Target Price
- DNTH $46.43
- TECX $72.25
- AVG Volume (30 Days)
- DNTH 285.9K
- TECX 118.2K
- Earning Date
- DNTH 11-07-2024
- TECX 02-24-2025
- Dividend Yield
- DNTH N/A
- TECX N/A
- EPS Growth
- DNTH N/A
- TECX N/A
- EPS
- DNTH N/A
- TECX N/A
- Revenue
- DNTH $5,366,000.00
- TECX N/A
- Revenue This Year
- DNTH $100.14
- TECX N/A
- Revenue Next Year
- DNTH N/A
- TECX N/A
- P/E Ratio
- DNTH N/A
- TECX N/A
- Revenue Growth
- DNTH 51.41
- TECX N/A
- 52 Week Low
- DNTH $14.82
- TECX $1.40
- 52 Week High
- DNTH $33.77
- TECX $53.41
- Technical
- Relative Strength Index (RSI)
- DNTH 45.12
- TECX 43.38
- Support Level
- DNTH $18.72
- TECX $37.07
- Resistance Level
- DNTH $28.65
- TECX $44.00
- Average True Range (ATR)
- DNTH 2.31
- TECX 3.06
- MACD
- DNTH -0.33
- TECX -0.57
- Stochastic Oscillator
- DNTH 32.14
- TECX 33.10
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.